Americas
Worldwide
Japan
Asia Pacific
Americas
Europe, Middle East, and Africa
Mizuho Bank
Mizuho Trust & Banking
Mizuho Securities
Search
Who We Are
Our People
Diversity & Inclusion
Awards
Locations
Americas
Brazil
Mexico
Events
What We Do
Banking
Overview
Industry Coverage
Consumer + Retail
Energy
Financial Institutions
Financial Sponsors
Healthcare
Industrials
Power + Utilities + Infrastructure
Real Estate
Technology + Media + Telecom
Corporate Banking
Debt Capital Markets
Equity Capital Markets
Leveraged Finance
Mergers & Acquisitions
Private Capital Advisory
Mizuho | Greenhill International Presence
Regional Coverage
Restructuring
Risk Solutions
Banking Insights
Markets
Overview
Equities
Fixed Income
Futures + Options
Research
Overview
Treasury Services
Overview
Commercial Card Programs
Insights + News
Insights
News
Press Releases
Sustainability
Sustainability
Community
Foundation
Media Relations
Press Releases-
Media Contacts & Resources-
Careers
Client Login
Futures-
US Equity Research-
Japan Equity Research-
Global Custody-
Commercial Card Portal-
Mizuho Americas
News
Biogen's Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst
Biogen's Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst
September 29, 2022
Share This
Latest Mizuho News
See all news
The winner of the OpenAI-Anthropic race may not be the first to the IPO finish line
June 9, 2026
Mizuho Americas wins five FCS Portfolio Awards
May 20, 2026
Mizuho Head of Investment: AI is imacting every sector in the global economy
June 9, 2026
Mizuho news from around the globe
Mizuho Global News
back-to-top-blue
